1448. Forgiveness of BIC/FTC/TAF: In Vitro Simulations of Intermittent Poor Adherence Find Limited HIV-1 Breakthrough and High Barrier to Resistance

BACKGROUND: Short lapses in adherence to ARVs can lead to virologic failure and emergence of resistance. Previous in vitro studies of regimen “forgiveness” simulated drug exposures of perfect adherence or short-term suboptimal adherence with bictegravir+emtricitabine+tenofovir alafenamide (BIC+FTC+T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulato, Andrew, Acosta, Rima K, Yant, Stephen R, Cihlar, Tomas, White, Kirsten L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776743/
http://dx.doi.org/10.1093/ofid/ofaa439.1629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776743/
http://dx.doi.org/10.1093/ofid/ofaa439.1629

Ejemplares similares